These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25500892)

  • 21. Characteristics of computed tomography perfusion parameters in non-small-cell-lung-cancer and its relationship to histology, size, stage an treatment response.
    Trinidad López C; Souto Bayarri M; Oca Pernas R; Delgado Sánchez-Gracián C; González Vázquez M; Vaamonde Liste A; Tardáguila De La Fuente G; De La Fuente Aguado J
    Clin Imaging; 2018; 50():5-12. PubMed ID: 29223410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving quantitative CT perfusion parameter measurements using principal component analysis.
    Yeung TP; Dekaban M; De Haan N; Morrison L; Hoffman L; Bureau Y; Chen X; Yartsev S; Bauman G; Lee TY
    Acad Radiol; 2014 May; 21(5):624-32. PubMed ID: 24703475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of duration of scan acquisition on CT perfusion parameter values in primary and metastatic tumors in the lung.
    Ng CS; Chandler AG; Wei W; Anderson EF; Herron DH; Kurzrock R; Charnsangavej C
    Eur J Radiol; 2013 Oct; 82(10):1811-8. PubMed ID: 23769187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer.
    Curvo-Semedo L; Portilha MA; Ruivo C; Borrego M; Leite JS; Caseiro-Alves F
    Acad Radiol; 2012 Feb; 19(2):203-13. PubMed ID: 22130088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.
    Reiner CS; Roessle M; Thiesler T; Eberli D; Klotz E; Frauenfelder T; Sulser T; Moch H; Alkadhi H
    Invest Radiol; 2013 Apr; 48(4):183-91. PubMed ID: 23328912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density.
    Ash L; Teknos TN; Gandhi D; Patel S; Mukherji SK
    Radiology; 2009 May; 251(2):422-8. PubMed ID: 19276321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advanced NSCLC first pass perfusion at 64-slice CT: reproducibility of volume-based quantitative measurement].
    Shan F; Zhang Z; Zeng M; Hu J; Bai C
    Zhongguo Fei Ai Za Zhi; 2010 May; 13(5):494-9. PubMed ID: 20677648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-contrast-enhanced preoperative assessment of lung perfusion in patients with non-small-cell lung cancer using Fourier decomposition magnetic resonance imaging.
    Sommer G; Bauman G; Koenigkam-Santos M; Draenkow C; Heussel CP; Kauczor HU; Schlemmer HP; Puderbach M
    Eur J Radiol; 2013 Dec; 82(12):e879-87. PubMed ID: 24041434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy Observation of Modified Yiqi Chutan Recipe Treating Mid-late Stage NSCLC Patients by CT Perfusion].
    Zheng XT; Lin LZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Feb; 36(2):155-9. PubMed ID: 27078989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance and mechanism of MSCT perfusion scan on differentiation of NSCLC].
    Liu JK; Hu CP; Zhou ML; Zhou H; Xiong Z; Xia Y; Chen W
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):460-4. PubMed ID: 19950560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of Therapeutic Effect of Chemotherapy for NSCLC Using Dual-Input Perfusion CT Analysis: Comparison among Bevacizumab Treatment, Two-Agent Platinum-based Therapy without Bevacizumab, and Other Non-Bevacizumab Treatment Groups.
    Yabuuchi H; Kawanami S; Iwama E; Okamoto I; Kamitani T; Sagiyama K; Yamasaki Y; Honda H
    Radiology; 2018 Feb; 286(2):685-695. PubMed ID: 29059037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractal analysis of CT perfusion images for evaluation of antiangiogenic treatment and survival in hepatocellular carcinoma.
    Hayano K; Lee SH; Yoshida H; Zhu AX; Sahani DV
    Acad Radiol; 2014 May; 21(5):654-60. PubMed ID: 24703479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multi-slice spiral CT pulmonary perfusion imaging and the expression of VEGF/PCNA in non-small cell lung cancer].
    Liu J; Xiong Z; Zhou H; Zhou M; Zhou J; Fu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 May; 34(5):406-11. PubMed ID: 19483288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapy.
    Lazanyi KS; Abramyuk A; Wolf G; Tokalov S; Zöphel K; Appold S; Herrmann T; Baumann M; Abolmaali N
    Lung Cancer; 2010 Dec; 70(3):280-5. PubMed ID: 20371133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of CT perfusion imaging in NSCLC and its correlation with angiogenesis and lymph node metastasis.
    Chen YS; Lin WH; Zhang AL; Lin Y
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2511-2516. PubMed ID: 33829437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of triple-phase thallium-201 SPECT in non-small-cell lung cancer (NSCLC): association with proliferative activity.
    Fujita S; Nagamachi S; Wakamatsu H; Nishii R; Futami S; Tamura S; Matsuzaki Y; Onizuka T; Hatakeyama K; Asada Y
    Ann Nucl Med; 2008 Dec; 22(10):833-9. PubMed ID: 19142701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT.
    Li Y; Yang ZG; Chen TW; Chen HJ; Sun JY; Lu YR
    Lung Cancer; 2008 Jul; 61(1):44-53. PubMed ID: 18055062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reproducibility of perfusion parameters obtained from perfusion CT in lung tumors.
    Ng CS; Chandler AG; Wei W; Anderson EF; Herron DH; Charnsangavej C; Kurzrock R
    AJR Am J Roentgenol; 2011 Jul; 197(1):113-21. PubMed ID: 21701018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT perfusion of renal cell carcinoma: impact of volume coverage on quantitative analysis.
    Reiner CS; Goetti R; Eberli D; Klotz E; Boss A; Pfammatter T; Frauenfelder T; Moch H; Sulser T; Alkadhi H
    Invest Radiol; 2012 Jan; 47(1):33-40. PubMed ID: 21730874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis of renal cell carcinoma: perfusion CT findings.
    Chen Y; Zhang J; Dai J; Feng X; Lu H; Zhou C
    Abdom Imaging; 2010 Oct; 35(5):622-8. PubMed ID: 19763683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.